Search clinical trials for: Docetaxel, trastuzumab and MM-111
Total 5928 results
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
Merrimack PharmaceuticalsCompletedBreast NeoplasmsUnited States
-
Merrimack PharmaceuticalsTerminatedColorectal Cancer | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung CancerUnited States
-
Merrimack PharmaceuticalsCompletedMetastatic Breast Cancer | Her2 Amplified Solid TumorsUnited States
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
InQpharm GroupCompleted
-
Pamela MunsterWithdrawnAdvanced Solid Tumor | Brain Metastases | Documented Her2 Overexpression | Neurologically Stable
-
Merrimack PharmaceuticalsSanofiCompletedAdvanced Solid TumorsUnited States
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
Merrimack PharmaceuticalsTerminatedStomach Cancer | Gastroesophageal Junction Cancer | HER-2 Gene Amplification | Esophagus CancerUnited States
-
Elevation OncologyMerrimack PharmaceuticalsTerminatedAdenocarcinoma | Non-Small Cell Lung Cancer | NSCLC | HeregulinSpain, Canada, United States, Germany, Hungary, France
-
European Organisation for Research and Treatment...GlaxoSmithKlineCompletedBreast CancerFrance, United Kingdom, Belgium, Switzerland, Slovenia
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
Finnish Breast Cancer GroupCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
Merrimack PharmaceuticalsUnknownBreast CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminated
-
Cancer Trials IrelandCompleted
-
SanofiMerrimack PharmaceuticalsCompletedSolid Tumor CancersUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Hebei Medical University Fourth HospitalOrigiMedRecruitingProspective | ObservationalChina
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Merrimack PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, France
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
SanofiCompletedBreast NeoplasmsFrance, Brazil, Poland, Germany, Belgium, Tunisia, United Kingdom, Uruguay
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Genentech, Inc.Completed
-
PfizerCompleted
-
Henan Cancer HospitalCompletedHER2 Positive Breast CancerChina
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompleted
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
AO Clinical Investigation and Publishing DocumentationCompletedHumerus Fractures | Closed Fracture of the Proximal HumerusBelgium, Austria, Germany, Switzerland
-
Danish Breast Cancer Cooperative GroupSanofi; Hoffmann-La RocheUnknown
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
R-PharmCompletedMetastatic Breast CancerItaly, Turkey, Spain, France, Greece
-
David BushnellVA Office of Research and DevelopmentCompleted
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastUnited States, France, Ireland
-
Merrimack PharmaceuticalsCompletedColorectal Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Squamous Cell Head and Neck CancerUnited States
-
Achieve Life SciencesUnknownNon-Small Cell Lung CancerTaiwan, Spain, Israel, Italy, Korea, Republic of, New Zealand, Australia, Germany, United States, Hungary, Poland, Russian Federation, Singapore, Thailand, Ukraine
-
Xuekui LiuNot yet recruiting